Key result
Point-of-care testing for cardiac troponin T reduced median overall hospital stay in patients eligible for early discharge compared to central laboratory testing.
Why the study?
Does point-of-care testing for cardiac troponin T reduce length of stay or mortality in patients with chest pain and suspected acute coronary syndrome?
RCT (n=263)
randomized
No
Does point-of-care testing for cardiac troponin T reduce length of stay or mortality in patients with chest pain and suspected acute coronary syndrome?
Point-of-care troponin testing combined with structured decision-making can significantly reduce hospital length of stay for early-discharge eligible patients with suspected acute coronary syndrome.
Answers are grounded in this paper and cite their sources.
Supports point-of-care troponin T testing to shorten stays in eligible suspected ACS patients; extends RCT evidence beyond central laboratory standards.
BACKGROUND: We report the results of a prospective randomized controlled trial comparing point-of-care testing (POCT) with central laboratory testing (CLT) in a six-bed coronary care unit in a district general hospital. METHODS: 263 consecutive admissions with chest pain and suspected acute coronary syndrome were randomized to measurement of cardiac troponin T by POCT or CLT only. Patient management was according to a pre-specified protocol utilizing clinical features, electrocardiographic changes and cardiac biomarkers (creatine kinase and cardiac troponin T) to define management. Outcome measures were diagnostic accuracy compared with CLT as 'gold standard', result turnaround time, mortality and length of stay in all patients and those with a protocol-driven early discharge policy. RESULTS: Diagnostic accuracy and mortality was equivalent in the POCT and CLT arm. Overall there was no difference in length of stay. In the pre-specified early discharge group (n = 64) there was a significant reduction in median length of non-coronary care unit stay (145.3 h versus 79.5 h) and overall hospital stay (209.3 h versus 149.9 h) in those randomized to POCT. CONCLUSION: A combination of rapid biochemical diagnosis and structured decision making reduces length of hospital stay.
No takes yet. Share an insight, caveat, or question.
Collinson et al. (2004) conducted an RCT in chest pain and suspected acute coronary syndrome (n=263). Point-of-care testing (POCT) for cardiac troponin T vs. Central laboratory testing (CLT) was evaluated on Diagnostic accuracy, result turnaround time, mortality, and length of stay. Point-of-care testing for cardiac troponin T reduced median overall hospital stay in patients eligible for early discharge compared to central laboratory testing.
Synapse has enriched 10 related papers. Consider them for comparative context: